Science Sparks @ ACTREC
21 September 2026Publications
- 1. Singh R, Budukh A, Kolekar S,Kumar G, Qayyumi B, Gupta T, Fatima ZH, Padvi N, Shivashankar S, Shah A, Gupta D, Kumar N, Prabhash K (2026). Profile of cancer cases at a rural cancer centre: insights from Homi Bhabha Cancer Hospital and Research Centre, Muzaffarpur, Bihar, India ecancer 20: 2213
- 2. Rai P, Janu AK (2026). From Opportunistic Chest CT to Predictive Radiology in MESA: An Early Career Perspective. Radiology. 320(3):e262439.
- 3. Chakrabarty N, Rane SU, Sherkhane U, More S, Shetty N, Ghosh Laskar S, Singh A, Noronha V, Prabhash K, Chaturvedi P (2026). MRI radiomics-based predictive modeling for risk stratification and prognostication in oral tongue carcinoma. Frontiers in Oncology. 16:1901400.
Interesting Reads
Video of the Week
Restructuring Clinical Care Models in Pancreatic Cancer
Upcoming Events
Sep 30-Oct 1, 2026
At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai
October 8-10, 2026
At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai
October 26-29, 2026
At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai.
Do You Know?
In 2012, Two seminal studies reveal the presence of mutations affecting the histone H3 genes in paediatric high-grade gliomas, including glioblastomas.
Cancer News
Nature, 17/09/2026
The Virtual Biotech comprises as many as 37,000 agents — AI systems that autonomously interact with large language models (LLMs) or with each other and are capable of performing multistep tasks. It uncovered a molecular signal that could help to predict clinical-trial success. And with some human oversight, it identified a promising lung-cancer treatment...
News-Medical, 17/09/2026
The new work identifies a key reason that a tumor can remain immunologically quiet: The cancer may fail to display useful molecular targets in the first place. T cells do not read a tumor's DNA directly. Instead, they inspect tiny protein fragments, so-called peptides, held on the cell surface by HLA molecules...
Sciencedaily, 16/09/2026
Scientists discovered a hidden “immune organ” inside the skull that acts as a rapid first responder against brain cancer in mice. Strengthening this local immune defense improved tumor rejection and survival, raising the possibility of new treatments that target the skull directly...
© 2026 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)